Chaolin Huang to Coronavirus Infections
This is a "connection" page, showing publications Chaolin Huang has written about Coronavirus Infections.
Connection Strength
0.075
-
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 02 15; 395(10223):497-506.
Score: 0.027
-
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med. 2020 Oct; 14(5):601-612.
Score: 0.007
-
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Pets in Wuhan, China. J Infect. 2020 09; 81(3):e68-e69.
Score: 0.007
-
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020 07; 21(7):904-913.
Score: 0.007
-
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care. 2020 05 14; 24(1):219.
Score: 0.007
-
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions. Front Med. 2020 Apr; 14(2):229-231.
Score: 0.007
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 05 07; 382(19):1787-1799.
Score: 0.007
-
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620953217.
Score: 0.007